{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:34:52Z","timestamp":1783154092649,"version":"3.54.6"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.humpath.2011.10.013","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T05:02:17Z","timestamp":1331096537000},"page":"1322-1327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified"],"prefix":"10.1016","volume":"43","author":[{"given":"Seiji","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Takino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kominato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2011.10.013_bb0005","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues.","first-page":"306","article-title":"Peripheral T-cell lymphoma, not otherwise unspecified","author":"Pileri","year":"2008"},{"key":"10.1016\/j.humpath.2011.10.013_bb0010","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.10.013_bb0015","first-page":"8820","article-title":"The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p","volume":"61","author":"Banham","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2011.10.013_bb0020","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nri953","article-title":"Lymphoid malignancies: the dark side of B-cell differentiation","volume":"12","author":"Shaffer","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humpath.2011.10.013_bb0025","doi-asserted-by":"crossref","first-page":"24259","DOI":"10.1074\/jbc.M207174200","article-title":"Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2011.10.013_bb0030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ni1358","article-title":"Foxp1 is an essential transcriptional regulator of B cell development","volume":"7","author":"Hu","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.humpath.2011.10.013_bb0035","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood-2004-03-1209","article-title":"Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma patients with poor outcome","volume":"104","author":"Barrans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.10.013_bb0040","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.1065.11.3","article-title":"Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma","volume":"11","author":"Banham","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.10.013_bb0045","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.10.013_bb0050","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1200\/JCO.2006.05.6150","article-title":"Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma","volume":"24","author":"Sagaert","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.10.013_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000212058","article-title":"FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa\u2013associated lymphoid tissue lymphomas","volume":"2","author":"Han","year":"2009","journal-title":"Dig Surg"},{"key":"10.1016\/j.humpath.2011.10.013_bb0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10549-007-9812-4","article-title":"Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor-beta in primary invasive breast carcinomas","volume":"3","author":"Bates","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2011.10.013_bb0065","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1158\/1078-0432.CCR-03-0461","article-title":"Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas","volume":"10","author":"Fox","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.10.013_bb0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1182\/blood-2009-07-232694","article-title":"Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development","volume":"3","author":"Feng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.10.013_bb0075","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.10.013_bb0080","first-page":"987","article-title":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma","volume":"14","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2011.10.013_bb0085","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"7","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.10.013_bb0090","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"16","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2011.10.013_bb0095","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1182\/blood-2007-09-115113","article-title":"Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell\u2013like subtype of DLBCL","volume":"5","author":"Brown","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.10.013_bb0100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/modpathol.3800781","article-title":"Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma","volume":"6","author":"Li","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.10.013_bb0105","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","article-title":"T-cell non-Hodgkin lymphoma","volume":"4","author":"Rizvi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.10.013_bb0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11899-010-0062-x","article-title":"Prognostic markers in peripheral T-cell lymphoma","volume":"4","author":"Piccaluga","year":"2010","journal-title":"Curr Hematol Malig Rep"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711004527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711004527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:33:30Z","timestamp":1758645210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817711004527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0046817711004527"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2011.10.013","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2011.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}